Skip to main content
Funded Studies

Albertus Antonius (Bart) Ellenbroek, PhD

Principle Scientist Neuropharmacology at Evotec AG

Location: Hamburg Germany

Dr. Ellenbroek is principle scientist neuropharmacology, working within the in vivo pharmacological group. He joined Evotec in 2006 after having worked in academia as an in vivo neuropharmacologist for over 15 years. His work focuses on in vivo animal modeling with special interest in animal models for CNS disorders, including Parkinson’s disease. Currently, he is involved in establishing and validating animal models for cognitive deficits, Huntington’s disease and other psychiatric and neurological indications.

Associated Grants

  • Investigation of PDE10a Inhibitors for Parkinsons Disease.PI is Bart Ellenbroek


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.